menu search

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus® ...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Facebook (fb) challenges help take markets south

An internal whistleblower came forward, claiming Facebook is favoring "profits over safety" and misleading investors....

October 4, 2021, 7:29 pm

Facebook (fb) challenges help take markets south

An internal whistleblower came forward, claiming Facebook is favoring "profits over safety" and misleading investors....

October 4, 2021, 7:29 pm

Facebook (fb) challenges help take markets south

An internal whistleblower came forward, claiming Facebook is favoring "profits over safety" and misleading investors....

October 4, 2021, 7:29 pm

Facebook (fb) challenges help take markets south

An internal whistleblower came forward, claiming Facebook is favoring "profits over safety" and misleading investors....

October 4, 2021, 7:29 pm

Facebook (fb) challenges help take markets south

An internal whistleblower came forward, claiming Facebook is favoring "profits over safety" and misleading investors....

October 4, 2021, 7:29 pm

Facebook (fb) challenges help take markets south

An internal whistleblower came forward, claiming Facebook is favoring "profits over safety" and misleading investors....

October 4, 2021, 7:29 pm

Facebook (fb) challenges help take markets south

An internal whistleblower came forward, claiming Facebook is favoring "profits over safety" and misleading investors....

October 4, 2021, 7:29 pm


Search within

Pages Search Results: